After failing to improve overall survival in unresectable metastatic bladder cancer in a phase 3 trial, this indication will be
Continue reading »
mypharmacynews.com
Home ยป Bladder Cancer
After failing to improve overall survival in unresectable metastatic bladder cancer in a phase 3 trial, this indication will be
Continue reading »NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. OPDIVO CMI _V17.0 (op-DEE-voh) Nivolumab (nee-vol-u-mab) Consumer
Continue reading »Scientists and physicians at Loyola University Chicago and Loyola Medicine were the first to publish groundbreaking research that debunked the
Continue reading »Columbia University Irving Medical Center (CUIMC) and NewYork-Presbyterian researchers have created patient-specific bladder cancer organoids that mimic many of the
Continue reading »